Compare Spotify Technology (SPOT) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Spotify Technology vs GeneDx Holdings Corp — how do they compare? Spotify Technology trades at $493.9 (market cap $101.23B), while GeneDx Holdings Corp trades at $60.45 (market cap $1.80B). The key difference: Spotify Technology is far larger — about 56.2× GeneDx Holdings Corp's market cap. Which is the better fit depends on your goals.
| SPOT | WGS | |
|---|---|---|
Market Cap | $101.23B | $1.80B |
Sector | Media | Technology |
52-Week High | $738.53 | $167.51 |
52-Week Low | $412.75 | $34.51 |
Enterprise Value | $91.81B | $1.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Spotify (SPOT) trades at $493.49, up 3.21% today, showing strong momentum after recent earnings beats. The stock faces technical resistance near $498 with bearish moving average signals. Fundamentally, the company demonstrates impressive growth with revenue reaching $17.19B in 2025 and net income surging to $2.21B, representing a 12.87% margin. Recent AI integration initiatives and expanded family account features highlight ongoing innovation.
Wall Street maintains a bullish stance with 61.5% buy ratings and a $617 consensus target, representing 25% upside potential. However, elevated valuation multiples (P/E 32.6, P/S 5.0) and competitive pressures from streaming rivals present near-term risks. The Q2 2026 earnings report will be crucial for validating the current growth trajectory.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Spotify Technology
Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
